Capital International Investors Legend Biotech Corp Transaction History

Capital International Investors

$557 Billion
Q2 2025

A detailed history of Capital International Investors transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International Investors holds 1,082,473 shares of LEGN stock, worth $40 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,082,473

Previous 1,677,260 35.46%

Holding current value

$40 Million

Previous $56.9 Million 32.5%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$27.69 - $37.91 $16.5 Million - $22.5 Million	-594,787 Reduced 35.46%	1,082,473 $38.4 Million
Q1 2025 May 12, 2025	SELL	$31.43 - $39.7 $15.2 Million - $19.2 Million	-484,244 Reduced 22.4%	1,677,260 $56.9 Million
Q4 2024 Feb 13, 2025	SELL	$32.49 - $50.28 $2.04 Million - $3.16 Million	-62,884 Reduced 2.83%	2,161,504 $70.3 Million
Q3 2024 Nov 13, 2024	BUY	$43.55 - $59.88 $2.69 Million - $3.69 Million	61,677 Added 2.85%	2,224,388 $108 Million
Q2 2024 Aug 13, 2024	SELL	$39.5 - $57.22 $725,338 - $1.05 Million	-18,363 Reduced 0.84%	2,162,711 $95.8 Million
Q1 2024 May 14, 2024	BUY	$55.06 - $69.99 $19.6 Million - $24.9 Million	356,387 Added 19.53%	2,181,074 $122 Million
Q4 2023 Feb 13, 2024	SELL	$57.25 - $69.74 $464,641 - $566,009	-8,116 Reduced 0.44%	1,824,687 $110 Million
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $1.84 Million - $2.23 Million	-29,206 Reduced 1.57%	1,832,803 $123 Million
Q2 2023 Aug 11, 2023	SELL	$46.28 - $75.01 $4.1 Million - $6.65 Million	-88,675 Reduced 4.55%	1,862,009 $129 Million
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $9.5 Million - $12.6 Million	-218,790 Reduced 10.08%	1,950,684 $94.1 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $27.7 Million - $39.6 Million	-713,286 Reduced 24.74%	2,169,474 $108 Million
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $6.15 Million - $9.2 Million	-161,206 Reduced 5.3%	2,882,760 $118 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $7.82 Million - $12.8 Million	233,229 Added 8.3%	3,043,966 $167 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $364,640 - $566,355	11,755 Added 0.42%	2,810,737 $102 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $4.65 Million - $6.45 Million	113,131 Added 4.21%	2,798,982 $130 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $52.1 Million - $83 Million	2,019,833 Added 303.27%	2,685,851 $110 Million
Q1 2021 May 14, 2021	SELL	$23.55 - $32.4 $649,273 - $893,268	-27,570 Reduced 3.97%	666,018 $19.3 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $25 Million - $29.5 Million	693,588 New	693,588 $29.5 Million

Others Institutions Holding LEGN

# of Institutions

237

Shares Held

60M

Call Options Held

591K

Put Options Held

381K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.19B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Legend Biotech Corp Transaction History